Skip to main content

CCNPP

Meet the Team

Quick Links

Administration Team

Profile Photo: Wesley Raup-Konsavage
Profile Photo: Diana Sepulveda
email icondqc5322@psu.edu

Basic Science Team

The basic science division utilizes pre-clinical models, such as in vitro studies and rodent models, to explore the potential therapeutic uses of cannabinoids for a variety of disease. Current projects are exploring the efficacy of cannabinoids or cannabis to treat cancer, acute and chronic pain, anxiety, high blood pressure and post-traumatic stress disorder (PTSD). Additional research within this group focuses on the chemistry of cannabinoids including pharmacokinetics, receptor binding and the development of novel cannabinoid-based compounds. These preclinical data will help to steer clinical research projects.

A professional photo of Neil Christensen
A professional photo of Dhimant Desai
email iconddesai@psu.edu
person iconPure
Profile Photo: Reyad Elbarbary
Profile Photo: Jeremy Hengst

Jeremy Hengst, PhD

Assistant Professor, Pediatrics

Profile Photo: Jiafen Hu
Profile Photo: Fadia Kamal

Fadia Kamal, PharmD, PhD

Director of Medical Student Research, Penn State College of Medicine

Profile Photo: Junxuan Lu

Junxuan Lu, PhD

Bernard B. Brodie Professor in Pharmacology, Neuroscience and Experimental Therapeutics

Profile Photo: Jeffrey Neighbors
Profile Photo: Leslie Parent
person iconPure
person iconFind a Doctor
A professional photo of Arati Sharma
email iconaks12@psu.edu
person iconPure
Profile Photo: Douglas Stairs
email icondbs18@psu.edu
person iconPure
Profile Photo: Jong Yun

Clinical Science Team

The clinical science division focuses on examining the benefits and potential harm of medical cannabis use for the current state-approved medical conditions. Currently, there are two teams within this division. The first team is focused on health outcomes in patients currently taking medical marijuana for the treatment of state-approved conditions, with special attention on anxiety, post-traumatic stress disorder and pain. The second team focuses on clinical trials, and they will be conducting double blind, placebo-controlled studies on the efficacy of cannabis to treat medical conditions and reduce reliance on opioids for pain.


Profile Photo: Matthew Coates

Matthew Coates, MD, PhD

Peter and Marshia Carlino Professor, Medicine

person iconPure
person iconFind a Doctor
Profile Photo: Kristin Riley
Profile Photo: Neal Thomas

Neal Thomas, MD, MSc

Associate Dean for Clinical Research, Penn State College of Medicine

email iconnjt7@psu.edu
person iconPure
person iconFind a Doctor
Profile Photo: Cristina Truica

Cristina Truica, MD

Associate Professor, Medicine

person iconPure
person iconFind a Doctor